Henrik Christensen is the founder of ImCheck Therapeutics. ImCheck Therapeutics has raised $154M in total funding. Latest round: Series B.
Hans Henrik Chrois Christensen is the CFO & COO at ImCheck Therapeutics, a French biotechnology company developing immuno-modulatory antibodies for cancer and other immune-related diseases. The company is headquartered in Marseille, France, and has raised multiple financing rounds.
Full founder directory · Investor directory · Company funding database · Fundraising library